Codiak BioSciences, Inc. announced that it has expanded its executive leadership team to support the continued advancement of its novel precision exosome therapeutics pipeline. Ajay Verma, M.D., Ph.D., joins Codiak as Senior Vice President, Head of Experimental Medicine and Neurology. In this new role, Dr. Verma will work to expand Codiak’s engEx Platform into serious neurological disorders and to develop novel endpoints and assessment tools for the company’s therapeutic candidates. Benny Sorensen, M.D., Ph.D., has been promoted to Senior Vice President, Head of Clinical Development. In this role, he will lead clinical development activities for Codiak’s therapeutic candidates, starting with exoSTING and exoIL-12, for which clinical trials are anticipated to begin in 2020. Both Drs. Verma and Sorensen will serve on the executive leadership team and report to Codiak’s president and CEO, Douglas E. Williams, Ph.D. Dr. Ajay Verma was most recently the Chief Medical Officer at United Neuroscience focusing on vaccines for neurological disorders. Prior to Codiak, Dr. Sorensen was Senior Director of Clinical Research at Alnylam Pharmaceuticals.